NCT06945614View on ClinicalTrials.gov

Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation

PHASE1RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 16, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Healthy Volunteer Study
Interventions
DRUG

Xenon gas inhalation

Administration of xenon gas in the mixture with oxygen for the period of time via inhalation

Trial Locations (1)

02115

RECRUITING

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

General Biophysics LLC

INDUSTRY

NCT06945614 - Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation | Biotech Hunter | Biotech Hunter